Pharma Latch

Pharma Latch is the only intradermal platform technology that can really deliver. The intradermal advantage to unlock the full potential of your therapeutic awaits. We have revolutionized the intradermal route, making it a reliable and accessible administration method for the pharmaceutical industry for the first time. This innovation enables a wide range of therapies to fully harness the proven benefits of intradermal drug delivery, unlocking their full therapeutic potential. Pharma Latch Hollow is a healthcare professional administered, sterile-packed, single-use medical device. The Pharma Latch Hollow is currently on the FDA 510(k) pathway for approval in the U.S. It introduces a device-based solution for injecting liquid formulations into the skin, is compatible with any Luer Lock or slip syringe, can deliver substances or drugs approved for intradermal delivery, and simplifies the procedure for the user and may remove the variability associated with traditional techniques by having device geometry govern needle insertion depth. The future of drug delivery is here, find out more by visiting https://pharmalatch.com/

• Employees 9
• Founded 2020
• Annual Revenue $6000000